Related Experiment Video
Updated: Feb 2, 2026

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
Microbiota of Inflammatory Bowel Disease Models
Animal models partially mimic human inflammatory bowel disease (IBD) gut microbiota. Inflammation in IBD reduces gut microbiome diversity and reveals specific microbial signatures in both models and patients.
Area of Science:
- Microbiology
- Gastroenterology
- Inflammatory Bowel Disease Research
Background:
- The gut microbiome is crucial in inflammatory bowel disease (IBD), a chronic intestinal inflammation affecting many people.
- Existing animal models for IBD are based on pathology, but their capacity to reflect patient gut microbiota remains unclear.
Purpose of the Study:
- To compare the fecal bacterial composition and biodiversity in rat models of two IBD subtypes with human patient samples.
- To assess the validity of animal models in recapitulating the gut microbiota of human IBD.
Main Methods:
- Fecal samples were collected from rat models of two IBD subtypes and human IBD patients.
- Bacterial population composition and biodiversity were analyzed.
- Metagenome prediction analysis was used to infer microbial functions.
Main Results:
- Inflammation was found to decrease overall microbiome diversity and increase inter-individual variability.
- Specific microbial signatures associated with IBD subtypes were identified and were consistent between animal models and human patients.
- Metagenome prediction suggested alterations in microbial functions due to host-microbiota interactions in IBD models.
Conclusions:
- Animal models can partially recapitulate the gut microbiota characteristic of human IBD.
- The identified microbial signatures offer potential biomarkers for IBD subtypes.
- Further research into host-microbiota interactions is warranted for understanding IBD pathogenesis.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

